Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 4Pancreatic Neoplasms 2Uterine Cervical Neoplasms 1Thyroid Cancer, Papillary 1Myasthenia Gravis 1Kidney Neoplasms 1Fanconi Anemia, Complementation Group D1 1Carcinoma, Intraductal, Noninfiltrating 1Breast Diseases 1Breast Carcinoma In Situ 1

Interventions

ravulizumab 3Tacrolimus 3Pyridostigmine Bromide 3Prednisone 3Mycophenolic Acid 3Data Collection 3Azathioprine 3efgartigimod alfa 2Steroids 2Diagnostic Self Evaluation 2Blood Specimen Collection 2rozanolixizumab 1Thymectomy 1Therapeutics 1Telemedicine 1Neurofeedback 1Methylprednisolone 1Methotrexate 1Immunosuppressive Agents 1Immunoglobulins, Intravenous 1Genotype 1Cyclosporine 1Cyclophosphamide 1Biomarkers 1Alleles 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Myasthenia Gravis × Genotype × Clear all
NCT05380128 2022-05-18

Association Study Between VDR Gene Polymorphisms and Risk and Features of MG in Han Chinese Population

Beijing Tongren Hospital

Completed
297 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡